Systematic Review: Certolizumab pegol for maintenance of medically induced remission in Crohn’s disease.
1 Jul, 2022 | 11:22h | UTCSummary: Certolizumab pegol for the treatment of maintaining inactive Crohn’s disease – Cochrane Library
Summary: Certolizumab pegol for the treatment of maintaining inactive Crohn’s disease – Cochrane Library